Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

219 Views

ViewAttendees 7

Session: Global Health & Mycobacteria

2354 - Implementation of BPaL in the United States: Experience using a novel all-oral treatment regimen for rifampin-resistant or treatment-intolerant TB disease

Saturday, October 22, 2022

3:45 PM – 4:00 PM US ET

Location: 204 ABC

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Presenting Author(s)

Connie A. Haley, MD MPH

Medical Consultant,
University of Florida
Nashville, Tennessee, United States

Disclosure: Disclosure(s): No financial relationships to disclose

Slides

Co-Author(s)

DA

David Ashkin, Director. Florida TB Controller

University of Miami / Florida Health Department
Miami, Florida, United States

Disclosure: Disclosure(s): No financial relationships to disclose
Charles A. Peloquin, Professor And The Jack C. Massey Professor; Division Head, Translational Research

Professor
University of Florida
Gainesville, Florida, United States

Disclosure: Disclosure(s): No financial relationships to disclose

Disclosure(s):

Connie A. Haley, MD MPH: No financial relationships to disclose

David Ashkin, Director. Florida TB Controller: No financial relationships to disclose

Charles A. Peloquin, Professor And The Jack C. Massey Professor; Division Head, Translational Research: No financial relationships to disclose